June 5, 2008 — A case study concerning the Axiom Worldwide’s DRX9000, published in the 2008 issue of the European Musculoskeletal Review, was mentioned in an online newsletter from the Food and Drug Administration (FDA).
The FDA news item was headlined, “Axiom Case Study Yields Favorable Findings with Back Pain Device.”
It read, in part, “A study evaluating Axiom Worldwide’s DRX9000 true nonsurgical spinal decompression system has produced positive results. … The study chronicled a patient who underwent 22 treatments with the device over a seven-week period and reported significant pain relief at the end of the study.”
Source: Axiom WorldWide, www.axiomworldwide.com
Related Posts
CMS releases new enrollment policies for providers- Celluma helps DCs, first responders amid COVID-19 pandemic
- Foundation for Chiropractic Progress helps ‘straighten up’ for World Spine Day
- How to use LinkedIn for your chiropractic business
- Future Health Inc. provides chiropractors with revenue-building videos
- Nordic Naturals reveals unique vertical integration process in “True North” documentary
